Cargando…

A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome

BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin-bin, Dai, En-lai, Xue, Guo-zhong, Ma, Rui-ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076150/
https://www.ncbi.nlm.nih.gov/pubmed/29979395
http://dx.doi.org/10.1097/MD.0000000000011282
_version_ 1783344654507311104
author Wang, Xin-bin
Dai, En-lai
Xue, Guo-zhong
Ma, Rui-ling
author_facet Wang, Xin-bin
Dai, En-lai
Xue, Guo-zhong
Ma, Rui-ling
author_sort Wang, Xin-bin
collection PubMed
description BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identify randomized controlled trials (RCTs) that compared the differences between different therapy regimens based on TwHF for patients with PNS. The risk of bias in included RCTs was evaluated according to the Cochrane Handbook version 5.2.0. Network meta-analysis was performed to compare different regimens. Primary outcomes were complete remission rate and total remission rate. The secondary outcomes were hr urinary protein excretion, serum albumin, serum creatinine, and urea nitrogen. Data analysis was performed using R software. RESULTS: A total of 40 studies involving 2846 patients with PNS were included. Compared with prednisone, the improvement in total remission rate and complete remission rate was associated with TwHF alone (odds ratio [OR] = 4.80, 95% credible intervals [CrI]: 2.20–10.00; OR = 6.30, 95% CrI: 2.90–13.00, respectively), TwHF+prednisone (OR = 2.10, 95% CrI: 1.30–3.50; OR = 2.40, 95% CrI: 1.50–3.80, respectively), TwHF+CPA (OR = 12.00, 95% CrI: 1.10–150.00; OR = 16.00, 95% CrI: 1.60–170.00, respectively), and TwHF+Cyclosporine A (OR = 28.00, 95% CrI: 3.20–250.00; OR = 35.00, 95% CrI: 4.50–270.00, respectively). Compared with TwHF alone, TwHF+prednisone showed less benefit in improving total remission rate and complete remission rate (OR = 0.44, 95% CrI: 0.21–0.91; OR = 0.38, 95% CrI: 0.19–0.77, respectively). TwHF alone, TwHF+prednisone could significantly reduce hr urinary protein excretion (MD = −0.69, 95% CrI: −1.30 to −0.14; MD = −1.00, 95% CrI: −1.90 to −0.14, respectively) and increase serum albumin (MD = 5.90, 95% CrI: 2.50–9.30; MD = 3.40, 95% CrI: 1.30–5.50, respectively) when compared to prednisone alone. TwHF alone showed significant reduction in serum creatinine when compared to CPA (MD = −19.00, 95% CrI: −37.00 to −0.56). CONCLUSIONS: TwHF alone, the addition TwHF to prednisone showed more benefit in improving total and complete remission rate, hr urinary protein excretion, serum albumin, and serum creatinine.
format Online
Article
Text
id pubmed-6076150
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-60761502018-08-17 A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome Wang, Xin-bin Dai, En-lai Xue, Guo-zhong Ma, Rui-ling Medicine (Baltimore) Research Article BACKGROUND: The present study aims to comprehensively determine the efficacy of different therapy regimens based on Tripterygium wilfordii Hook F (TwHF) for patients with primary nephrotic syndrome (PNS) using network meta-analysis method. METHODS: Seven electronic databases were searched to identify randomized controlled trials (RCTs) that compared the differences between different therapy regimens based on TwHF for patients with PNS. The risk of bias in included RCTs was evaluated according to the Cochrane Handbook version 5.2.0. Network meta-analysis was performed to compare different regimens. Primary outcomes were complete remission rate and total remission rate. The secondary outcomes were hr urinary protein excretion, serum albumin, serum creatinine, and urea nitrogen. Data analysis was performed using R software. RESULTS: A total of 40 studies involving 2846 patients with PNS were included. Compared with prednisone, the improvement in total remission rate and complete remission rate was associated with TwHF alone (odds ratio [OR] = 4.80, 95% credible intervals [CrI]: 2.20–10.00; OR = 6.30, 95% CrI: 2.90–13.00, respectively), TwHF+prednisone (OR = 2.10, 95% CrI: 1.30–3.50; OR = 2.40, 95% CrI: 1.50–3.80, respectively), TwHF+CPA (OR = 12.00, 95% CrI: 1.10–150.00; OR = 16.00, 95% CrI: 1.60–170.00, respectively), and TwHF+Cyclosporine A (OR = 28.00, 95% CrI: 3.20–250.00; OR = 35.00, 95% CrI: 4.50–270.00, respectively). Compared with TwHF alone, TwHF+prednisone showed less benefit in improving total remission rate and complete remission rate (OR = 0.44, 95% CrI: 0.21–0.91; OR = 0.38, 95% CrI: 0.19–0.77, respectively). TwHF alone, TwHF+prednisone could significantly reduce hr urinary protein excretion (MD = −0.69, 95% CrI: −1.30 to −0.14; MD = −1.00, 95% CrI: −1.90 to −0.14, respectively) and increase serum albumin (MD = 5.90, 95% CrI: 2.50–9.30; MD = 3.40, 95% CrI: 1.30–5.50, respectively) when compared to prednisone alone. TwHF alone showed significant reduction in serum creatinine when compared to CPA (MD = −19.00, 95% CrI: −37.00 to −0.56). CONCLUSIONS: TwHF alone, the addition TwHF to prednisone showed more benefit in improving total and complete remission rate, hr urinary protein excretion, serum albumin, and serum creatinine. Wolters Kluwer Health 2018-07-06 /pmc/articles/PMC6076150/ /pubmed/29979395 http://dx.doi.org/10.1097/MD.0000000000011282 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Wang, Xin-bin
Dai, En-lai
Xue, Guo-zhong
Ma, Rui-ling
A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title_full A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title_fullStr A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title_full_unstemmed A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title_short A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome
title_sort prisma-compliant systematic review and network meta-analysis on the efficacy between different regimens based on tripterygium wilfordii hook f in patients with primary nephrotic syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076150/
https://www.ncbi.nlm.nih.gov/pubmed/29979395
http://dx.doi.org/10.1097/MD.0000000000011282
work_keys_str_mv AT wangxinbin aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT daienlai aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT xueguozhong aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT maruiling aprismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT wangxinbin prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT daienlai prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT xueguozhong prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome
AT maruiling prismacompliantsystematicreviewandnetworkmetaanalysisontheefficacybetweendifferentregimensbasedontripterygiumwilfordiihookfinpatientswithprimarynephroticsyndrome